Loading clinical trials...
Loading clinical trials...
The investigators aim to compare the efficacy and safety of secukinumab and ustekinumab in patients with generalized pustular psoriasis (GPP), and to explore the impact of genetic mutation types on cl...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Chao Ji
NCT06100991 · Generalized Pustular Psoriasis
NCT06477536 · Generalized Pustular Psoriasis
NCT06323356 · Generalized Pustular Psoriasis, Erythrodermic Psoriasis
NCT07448428 · Generalized Pustular Psoriasis, Generalized Pustular Psoriasis (GPP)
NCT06886009 · Generalized Pustular Psoriasis
First Affiliated Hospital of Fujian Medical University
Fuzhou, Fujian
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions